期刊文献+

关节镜手术联合富血小板血浆治疗半月板损伤临床疗效 被引量:25

The clinical efficacy of arthroscopic surgery combined with platelet-rich plasma in meniscus injury patients
下载PDF
导出
摘要 目的评价富血小板血浆(PRP)应用于膝关节半月板损伤行关节镜缝合修复术后患者的临床效果。方法选择2013年5月至2014年5月半月板损伤患者28例,采用随机对照方法将患者分为两组:PRP组14例,为关节镜联合应用PRP组;关节镜组14例,为单纯关节镜治疗组。随访时间3-12个月,观察两组患者治疗后Lysholm评分、膝关节损伤和骨关节炎结果评分(KOOS)及临床疗效。结果随访发现两组患者术后分别有1例患者在术后1年接受半月板切除术,其余患者关节症状均好转;与治疗前比较,两组患者治疗后Lysholm评分显著提高(P〈0.01),治疗后两组患者间比较差异无统计学意义(P〉0.05);两组患者治疗后KOOS评分指标中,疼痛和体育运动评分比较差异有统计学意义(P〈0.05),其余指标比较差异无统计学意义(P〉0.05)。结论关节镜下行半月板损伤修复手术有创伤小、恢复快及并发症少等优点。联合应用PRP治疗,其临床疗效改善并不明显,进一步探讨PRP在半月板损伤修复中的临床作用,未来需要更多前瞻性研究。 Objective To evaluate the clinical efficacy of platelet-rich plasma(PRP)combined arthroscopic suture repair in the treatment of knee joint meniscus injury.Methods Totally 28 patients suffered from meniscus injury of knee joint during May2013 to May 2014 were randomly divided into 2groups:PRP group(n=14),arthroscopy suture repair combined with PRP;Arthroscopy group(n=14),arthroscopic suture repair was the only treatment.Followed up for 3to 12 months,lysholm knee score scale(LKSS),knee injury and osteoarthritis score(KOOS)and complication were recorded.Results One year follow-up showed that one patient of each groups were found to required knee joint meniscectomy,the rest of the joints in patients with symptoms were improved.The Lysholm score in two groups was significantly improved after treatment(P〈0.01),but there was no significant difference between the two groups after treatment(P〉0.05).The pian and sport score of KOSS had significantly differences in two groups(P〈0.05),and other indicators had no statistically significant difference(P〉0.05).Conclusion Arthroscopic meniscus injury repair has the advantages of less invasive,faster recovery and fewer complications.Clinical efficacy improvement was not significant combined with PRP treatment.We need more RCTs and cases to investigate the clinical efficacy in future.
出处 《重庆医学》 CAS 北大核心 2015年第36期5079-5081,共3页 Chongqing medicine
基金 南京医科大学科技发展基金资助项目(2013njmu149)
关键词 富血小板血浆 关节镜 半月板损伤 修复 platelet-rich plasma arthroscopy meniscus injury repair
  • 相关文献

参考文献16

  • 1Espejo-Reina A, Serrano-Ferndndez JM, Martin-Castilla B, et al. Outcomes after repair of chronic bucket-handle tears of medial meniscus[J]. Arthroscopy, 2014,30 (4) : 492-496.
  • 2詹子睿.关节镜技术治疗半月板损伤50例临床观察[J].吉林医学,2010,31(17):2574-2575. 被引量:6
  • 3Bekkers JE, De Windt TS, Raijmakers NJ, et al. Valida- tion of the knee injury and osteoarthritis outcome score (KOOS) for the treatment of focal cartilage lesions[J]. Osteoarthritis Cartilage, 2009,17 (11) : 1434-1439.
  • 4Becket R,Pufe T, Kulow S, et al. Expression of vascular endothelial growth factor during healing of the meniscus in a rabbit model[J]. J Bone Joint Surg Br,2004,86(7) : 1082-1087.
  • 5Kobayashi K, Fujimoto E,Deie M, et al. Regional differ- ences in the healing potential of the meniscus-an organ culture model to eliminate the influence of microvascula- ture and the synovium[J]. Knee, 2004,11(4) : 271-278.
  • 6Makris EA, Hadidi P, Athanasiou KA. The knee menis- cus: structure-function, pathophysiology, current repair techniques,and prospects for regeneration[J]. Biomateri-als, 2011,32 (30) : 7411-7431.
  • 7Noyes FR, Barber-Westin SD. Management of meniscus tears that extend into the avascular region[J]. Clin Sports Med,2012,31 (1) :65-90.
  • 8Marx RE. Platelet-rich plasma: evidence to support its use [J].J Oral Maxillofac Surg, 2004,62 (4) : 489-496.
  • 9熊隆江,练克俭.富血小板血浆凝胶及其在骨科的应用[J].中国骨与关节损伤杂志,2005,20(7):500-502. 被引量:4
  • 10Cole BJ, Seroyer ST, Filardo G, et al. Platelet-rich plas- ma: where are we now and where are we going? [J]. Sports Health,2010,2(3) :203-210.

二级参考文献23

  • 1Hall AJ.Meniscal repair VS meniscectomy(by K.G.Sommerlath)[J].In Orthop,1999,15(4):350.
  • 2Weibrich G, Kleis WK, Hafner G, et al. Growth factor levels in the platelet - rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg, 2002, 30 (2): 97.
  • 3Kazuhiro Okuda, Tomoyuki Kawase, Manabu Momose et al. Platelet -rich plasma contains high levels of platelet - derived growth factor and transforming growth factor- beta and modulates the proliferation of periodongtally related cells in vitro. J Periodontol, 2003,74:849.
  • 4Bouletreau PJ, Warrren SM, Spector JA . Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast ReconstrSurg, 2002, 110:139.
  • 5Homer A, Kemp P, Summers. et al. Expression and distribution of transforming growth factor- beta isoforms and their signaling receptors in growing human bone. Bone, 1998, 23:95.
  • 6Regina Landesberg, Martin Roy, Robert S. Quantification of growth factor levels using a simplified method of platelet - rich plasma gel preparation. J Oral Maxillofac Surg, 2003, 58 (3): 297.
  • 7Carlson ER. Bone grafting the jaws in the 21st century: The use of platelet- rich plasma and bone morphogenetic protein. Alpha Omegan, 2000, 93 (3): 26.
  • 8Tsunawaki S. Deactivation of macrophages by transforming growth factor beta. Nature, 1988, 334:260.
  • 9Marx RE, Carlson ER, Eichstaedt RM. et al. Platelet- rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998, 85 (6): 638.
  • 10Assoian RK, Grotedorst GR, Muller DM, et al. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature , 1984, 309 (5971): 804.

共引文献8

同被引文献185

引证文献25

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部